Business
ASX 200 expected to drop lower amid COVID-19 vaccine concerns
The S&P/ASX 200 Index (ASX: XJO) is expected to drop lower this morning, with SPI futures currently pointing to a 0.3% decline at the open.
This decline appears to have been driven by concerns over the AstraZeneca-Oxford University COVID-19 vaccine candidate, AZD1222.
What has happened?
Last week AstraZeneca revealed that its phase three trial data showed that its vaccine candidate was highly effective against COVID-19 with certain dosages.
The data showed that when trial participants were given a half dose, followed by a full dose at least one month apart, the vaccine was 90% effective. Whereas, when given as two full doses at least one month apart, the vaccine showed just 62% efficacy.
Overnight, the pharmaceutical giant…
-
Noosa News19 hours agoBrisbane nation’s third-youngest capital; Leaders condemn anti-immigration rally
-
General23 hours agoAs Iran-Australia relations plunge to a new low, Tehran faces another diplomatic setback
-
Noosa News10 hours agoPill checking to resume in Queensland months after government axed funding
-
Business12 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today